Literature DB >> 11453659

BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).

N E Heldin.   

Abstract

The aim of the present study was to investigate the effect of bone morphogenetic protein (BMP-7) on thyroid carcinoma cell growth. Addition of BMP-7 inhibited the proliferation of four out of six human anaplastic thyroid carcinoma cell lines, observed as decreased incorporation of (3)H-thymidine and decreased cell number. The growth inhibitory effect was cell density-dependent; sparse cells were inhibited by BMP-7 whereas dense cells were not. Cell cycle analysis by flow cytometry showed an increased fraction of cells in the G1-phase and subsequent decrease in both S- and G2/M-phase after BMP-7 stimulation. Furthermore, BMP-7 caused an upregulation of the cyclin-dependent kinase inhibitors (CDKIs) p21 and p27, decreased activity of Cdk2 and Cdk6, and hypophosphorylation of the retinoblastoma protein (pRb). These findings suggest a growth inhibitory effect of BMP-7 on anaplastic thyroid carcinoma cells by inhibition of Cdk activity shifting the Rb protein to the hypophosphorylated state. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453659     DOI: 10.1006/bbrc.2001.5212

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum.

Authors:  Yanxin Pei; Sonja N Brun; Shirley L Markant; William Lento; Paul Gibson; Makoto M Taketo; Marco Giovannini; Richard J Gilbertson; Robert J Wechsler-Reya
Journal:  Development       Date:  2012-03-29       Impact factor: 6.868

Review 2.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

3.  Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.

Authors:  Z-B Song; P Wu; J-S Ni; T Liu; C Fan; Y-L Bao; Y Wu; L-G Sun; C-L Yu; Y-X Huang; Y-X Li
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

Review 4.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

5.  Anaplastic thyroid carcinoma: a therapeutic dilemma.

Authors:  Hang-Seok Chang; Kee-Hyun Nam; Woung Youn Chung; Cheong Soo Park
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

6.  A human bone morphogenetic protein antagonist is down-regulated in renal cancer.

Authors:  Kimberly Rose Blish; Wei Wang; Mark C Willingham; Wei Du; Charles E Birse; Surekha R Krishnan; Julie C Brown; Gregory A Hawkins; A Julian Garvin; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Mol Biol Cell       Date:  2007-11-21       Impact factor: 4.138

7.  BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21 CIP1 and p27 KIP1 regulation.

Authors:  Shun-Fu Chang; Ting-Kuo Chang; Hsin-Hsin Peng; Yi-Ting Yeh; Ding-Yu Lee; Chiuan-Ren Yeh; Jing Zhou; Cheng-Kung Cheng; Cheng Allen Chang; Jeng-Jiann Chiu
Journal:  Mol Endocrinol       Date:  2009-10-09

8.  Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.

Authors:  Marcin Kowanetz; Ulrich Valcourt; Rosita Bergström; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.

Authors:  Julia Dambacher; Florian Beigel; Julia Seiderer; Dirk Haller; Burkhard Göke; Christoph J Auernhammer; Stephan Brand
Journal:  Gut       Date:  2007-04-20       Impact factor: 23.059

10.  Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors.

Authors:  Helena Wensman; Nils-Erik Heldin; Gunnar Pejler; Eva Hellmén
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.